Rigel Pharmaceuticals, Inc. Share Price
NASDAQ: RIGL | Small CapRigel Pharmaceuticals, Inc. Stock Performance
Rigel Pharmaceuticals, Inc. Share Price Today
As of 30 October 2026, Rigel Pharmaceuticals, Inc.'s share price is $51.17. The stock opened at $51.38, compared to its previous close of $51.28. During today's trading session, Rigel Pharmaceuticals, Inc.'s share price traded between $50.94 and $51.40, with an average price of $51.17. Over the past 52 weeks, the stock has recorded a high of $52.05 and a low of $25.07. In terms of performance, Rigel Pharmaceuticals, Inc.'s share price has risen by 76.97% over the last six months and is up 62.03% on a year-on-year basis.
Rigel Pharmaceuticals, Inc. Share Price Chart
Rigel Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Rigel Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
Rigel Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $48.09 | $50.94 | +5.93% |
Sep 2026 | $46.81 | $48.09 | +2.64% |
Aug 2026 | $36.67 | $46.85 | +27.29% |
Jul 2026 | $38.97 | $36.81 | -5.90% |
Jun 2026 | $30.35 | $39.12 | +28.22% |
May 2026 | $29.44 | $30.51 | +5.52% |
Apr 2026 | $27.44 | $28.91 | +6.84% |
Mar 2026 | $33.88 | $27.07 | -21.85% |
Feb 2026 | $34.73 | $34.63 | -0.03% |
Jan 2026 | $42.67 | $34.64 | -19.06% |
Dec 2025 | $49.75 | $42.80 | -15.33% |
Nov 2025 | $31.30 | $50.55 | +60.05% |